Related Experiment Video
Updated: Aug 17, 2026

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer
R I Nicholson1, R A McClelland, J F Robertson
1Tenovus Cancer Research Centre, University of Wales College of Medicine, Cardiff, UK.
Abstract:
Multiple lines of evidence implicate steroid hormone and growth factor cross-talk as a modulator of endocrine response in breast cancer and that aberrations in growth factor signaling pathways are a common element in the endocrine resistant phenotype. Delineation of these relationships is thus an important diagnostic goal in cancer research, while the targeting of aberrant growth factor signaling holds the promise of improving therapeutic response rates.
Insights
Steroid hormone and growth factor interactions influence breast cancer endocrine response. Understanding these pathways is key for improving breast cancer treatment and overcoming endocrine resistance.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Steroid hormone and growth factor signaling pathways are crucial in breast cancer development and progression.
- Aberrations in these pathways contribute to endocrine resistance, a major challenge in breast cancer treatment.
Purpose of the Study:
- To investigate the cross-talk between steroid hormone and growth factor signaling in breast cancer.
- To understand the role of these interactions in endocrine response and resistance.
Main Methods:
- The study likely involved analyzing molecular signaling pathways in breast cancer cells or tissues.
- Methods may include techniques like gene expression analysis, protein interaction studies, and functional assays.
Main Results:
- Evidence suggests that the interplay between steroid hormones and growth factors modulates endocrine response in breast cancer.
- Disruptions in growth factor signaling are frequently observed in endocrine-resistant breast cancer phenotypes.
Conclusions:
- Delineating the relationships between steroid hormone and growth factor signaling is a critical diagnostic objective in cancer research.
- Targeting aberrant growth factor signaling pathways presents a promising strategy to enhance therapeutic efficacy and overcome endocrine resistance in breast cancer.
Related Concept Videos
Mitogens and the Cell Cycle
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

